Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
Open | $3.67 |
Close | - |
Volume / Avg. | 1.59K / 32.13K |
Day Range | 3.51 - 3.67 |
52 Wk Range | 2.89 - 30.06 |
Market Cap | $2.22M |
P/E Ratio | 0.27 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 9.68% |
Days to Cover | 3.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Windtree Therapeutics (NASDAQ:WINT) through any online brokerage.
Other companies in Windtree Therapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA) and Entero Therapeutics (NASDAQ:ENTO).
There is no analysis for Windtree Therapeutics.
Windtree Therapeutics has a consensus price target of $1.00.
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $3.535 last updated Today at July 22, 2024 at 12:11 PM EDT.
There are no upcoming dividends for Windtree Therapeutics.
Windtree Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Windtree Therapeutics.
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.